Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis.
Standard
Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis. / Keller, Johannes; Catalá-Lehnen, Philip; Wintges, Kristofer; Schulze, Jochen; Bickert, Thomas; Ito, Wulf; Horst, Andrea; Amling, Michael; Schinke, Thorsten.
in: BIOCHEM BIOPH RES CO, Jahrgang 417, Nr. 1, 1, 2012, S. 217-222.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis.
AU - Keller, Johannes
AU - Catalá-Lehnen, Philip
AU - Wintges, Kristofer
AU - Schulze, Jochen
AU - Bickert, Thomas
AU - Ito, Wulf
AU - Horst, Andrea
AU - Amling, Michael
AU - Schinke, Thorsten
PY - 2012
Y1 - 2012
N2 - Interleukin-33 (IL-33) is the most recently identified member of the IL-1 family of cytokines, which is primarily known for its proinflammatory functions. We have previously reported that IL-33 is expressed by bone-forming osteoblasts, and that administration of recombinant IL-33 to bone marrow cultures inhibits their differentiation into bone-resorbing osteoclasts. Likewise, while the inhibitory effect of IL-33 on osteoclast differentiation was fully abolished in cultures lacking the IL-33 receptor ST2, mice lacking ST2 displayed low bone mass caused by increased osteoclastogenesis. Although these data suggested a physiological role of IL-33 as an inhibitor of bone resorption, direct in vivo evidence supporting such a function was still missing. Here we describe the generation and bone histomorphometric analysis of a transgenic mouse model (Col1a1-Il33) over-expressing IL-33 specifically in osteoblasts. While we did not observe differences in osteoblast number and bone formation between wildtype and Col1a1-Il33 mice, the number of osteoclasts was significantly reduced compared to wildtype littermates in two independent transgenic lines. Since we did not observe quantitative differences in the populations of eosinophils, neutrophils, basophils or M2-macrophages from the bone marrow of wildtype and Col1a1-Il33 mice, our data demonstrate that an inhibition of osteoclastogenesis is one of the major physiological functions of IL-33, at least in mice.
AB - Interleukin-33 (IL-33) is the most recently identified member of the IL-1 family of cytokines, which is primarily known for its proinflammatory functions. We have previously reported that IL-33 is expressed by bone-forming osteoblasts, and that administration of recombinant IL-33 to bone marrow cultures inhibits their differentiation into bone-resorbing osteoclasts. Likewise, while the inhibitory effect of IL-33 on osteoclast differentiation was fully abolished in cultures lacking the IL-33 receptor ST2, mice lacking ST2 displayed low bone mass caused by increased osteoclastogenesis. Although these data suggested a physiological role of IL-33 as an inhibitor of bone resorption, direct in vivo evidence supporting such a function was still missing. Here we describe the generation and bone histomorphometric analysis of a transgenic mouse model (Col1a1-Il33) over-expressing IL-33 specifically in osteoblasts. While we did not observe differences in osteoblast number and bone formation between wildtype and Col1a1-Il33 mice, the number of osteoclasts was significantly reduced compared to wildtype littermates in two independent transgenic lines. Since we did not observe quantitative differences in the populations of eosinophils, neutrophils, basophils or M2-macrophages from the bone marrow of wildtype and Col1a1-Il33 mice, our data demonstrate that an inhibition of osteoclastogenesis is one of the major physiological functions of IL-33, at least in mice.
KW - Animals
KW - Mice
KW - Mice, Transgenic
KW - Collagen Type I/genetics
KW - Interleukins/genetics/physiology
KW - Osteoblasts/cytology/physiology
KW - Transgenes
KW - Animals
KW - Mice
KW - Mice, Transgenic
KW - Collagen Type I/genetics
KW - Interleukins/genetics/physiology
KW - Osteoblasts/cytology/physiology
KW - Transgenes
M3 - SCORING: Journal article
VL - 417
SP - 217
EP - 222
JO - BIOCHEM BIOPH RES CO
JF - BIOCHEM BIOPH RES CO
SN - 0006-291X
IS - 1
M1 - 1
ER -